MALOSA LIMITED
Company number 04206780 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Credit Analysis: MALOSA LIMITED
1. Credit Opinion: CONDITIONAL
Reasoning: The credit application warrants a conditional approach due to several governance and structural concerns that require mitigation before full approval. While the company benefits from long-standing operations (incorporated 2001) and operates in a resilient medical devices sector, significant red flags exist around ownership transparency and recent board instability. The absence of filed financial data in this review prevents full quantitative analysis, and the offshore ownership structure introduces enforcement risk. Any credit facility should be conditional upon satisfactory financial disclosure and clarification of the control structure.
2. Financial Strength
Limited Assessment Available
- Share Capital: £165 — This is exceptionally minimal and suggests the company is severely undercapitalised on an equity basis, or alternatively, operations are funded through intercompany arrangements rather than share capital.
- No Balance Sheet Data Available: Without access to filed financial statements showing fixed assets, current assets, liabilities, and net assets, a full assessment of balance sheet health is not possible.
- Holding Company Structure: The SIC code 64209 (Activities of other holding companies) alongside manufacturing (32500) suggests the company may serve as both an operating entity and a holding vehicle. This can obscure true financial position through intercompany balances.
- Intercompany Dependencies: Given the PSC structure (see below), the company is likely part of a larger group. Financial strength may depend heavily on parent company support, which must be evaluated.
Concern: The minimal share capital and lack of visible financial reserves raises questions about the company's standalone balance sheet resilience.
3. Cash Flow Assessment
Unable to Complete Full Assessment
No cash flow, turnover, or working capital data is available from the provided information. The following cannot be determined: - Revenue generation capacity - Operating cash flow adequacy - Working capital position (current assets vs. current liabilities) - Debt service coverage ratios - Liquidity buffers
Structural Observations: - As a subsidiary of what appears to be Beaver-Visitec International (a known ophthalmic surgical products group), cash flow may be heavily influenced by group treasury arrangements. - Intercompany funding arrangements could distort standalone liquidity metrics. - Any credit assessment should request consolidated and standalone financial statements.
4. Monitoring Points
Immediate Concerns Requiring Clarification
| Issue | Risk Level | Action Required |
|---|---|---|
| Offshore Ownership (BVI) | High | Bvi Ovington Limited is incorporated in the British Virgin Islands, a jurisdiction with limited transparency. Clarify ultimate beneficial ownership and provide documented source of funds. |
| Overlapping PSC Declarations | High | Two entities (Bvi Ovington Limited and Beaver-Visitec International (UK) Limited) both claim >75% share ownership, plus an individual claims 50-75%. This is mathematically inconsistent and suggests either a chain of ownership or filing errors. Clarify the actual ownership chain. |
| Recent Director Resignations | Medium | Three directors resigned in early-mid 2026 (Patriacca, Korangy, Richardson). This level of board turnover within months warrants explanation — is this restructuring, strategic changes, or governance concerns? |
| Minimal Share Capital | Medium | £165 share capital is nominal. Understand how the business is funded and whether there are distributable reserves or intercompany loans supporting operations. |
| Financial Filing Compliance | Low | Accounts are current and not overdue, which is positive. Continue to monitor filing timeliness. |
Ongoing Monitoring Metrics
- Filing Compliance: Ensure accounts and confirmation statements remain timely filed
- Director Stability: Monitor for further board changes that could signal instability
- Group Financial Health: Assess the parent company (Beaver-Visitec International) financial position, as group distress would likely cascade
- Intercompany Balances: Track any related-party receivables/payables that could affect liquidity
- Industry Conditions: Medical device manufacturing is generally defensive, but monitor for regulatory changes or supply chain disruptions
Suggested Facility Conditions
- Personal/Corporate Guarantees: Required from ultimate parent entity or Bvi Ovington Limited (subject to enforceability review)
- Financial Covenants: To be established once financial statements are provided
- Negative Pledge: Restrict additional borrowing without lender consent
- Group Support Letter: Formal comfort letter from parent company confirming ongoing support